Gilead, Feds Resolve HIV Drug Patent Dispute Amid Appeal
By Hailey Konnath · January 15, 2025, 11:03 PM EST
Gilead Sciences and the federal government have agreed to dismiss all claims and counterclaims in a yearslong intellectual property and contract battle over HIV prevention drugs Truvada and Descovy, according to stipulations...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login